Related Experiment Videos

Systemic release of mucosal mast-cell protease in primed rats challenged with Nippostrongylus brasiliensis

Immunology
|July 1, 1983
PubMed

Insights

Systemic secretion of rat mast-cell protease II (RMCPII) indicates mucosal mast cell (MMC) activation during N. brasiliensis infection. Measuring RMCPII in serum offers a sensitive assay for MMC involvement in mucosal reactions.

Area of Science:

  • Immunology
  • Parasitology
  • Biochemistry

Background:

  • Mucosal mast cells (MMC) are key players in immune responses at mucosal surfaces.
  • Rat mast-cell protease II (RMCPII) is a major secretory product of MMC.
  • Nematode infections, such as N. brasiliensis, are known to elicit mast cell responses.

Purpose of the Study:

  • To measure the systemic secretion of RMCPII in rats challenged with N. brasiliensis.
  • To assess the utility of serum RMCPII levels as a marker for MMC activation.
  • To investigate the effect of parasite antigens on MMC and RMCPII levels.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to quantify serum RMCPII levels.
  • Rats were either naive or primed and challenged with N. brasiliensis worms or soluble worm antigen.
  • RMCPII levels in serum and jejunal content were measured at various time points.

Main Results:

  • Systemic RMCPII secretion was time- and dose-dependent in primed rats following N. brasiliensis challenge.
  • Primed rats showed significantly higher serum RMCPII levels after challenge or antigen exposure compared to naive rats.
  • Intravenous administration of worm antigen to primed rats resulted in a marked increase in serum RMCPII and a reduction in jejunal MMC and RMCPII.
  • Morphological changes in MMC and jejunal RMCPII content were observed, indicating activation and degranulation.

Conclusions:

  • MMC are unequivocally activated in response to N. brasiliensis infection and parasite antigens.
  • Serum RMCPII detection provides a sensitive and selective assay for evaluating MMC participation in mucosal pathologies.
  • This study validates RMCPII as a biomarker for MMC activation in parasitic infections.

Related Concept Videos